These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23414845)

  • 1. Structure-based discovery of cellular-active allosteric inhibitors of FAK.
    Tomita N; Hayashi Y; Suzuki S; Oomori Y; Aramaki Y; Matsushita Y; Iwatani M; Iwata H; Okabe A; Awazu Y; Isono O; Skene RJ; Hosfield DJ; Miki H; Kawamoto T; Hori A; Baba A
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1779-85. PubMed ID: 23414845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of novel allosteric FAK inhibitors.
    Iwatani M; Iwata H; Okabe A; Skene RJ; Tomita N; Hayashi Y; Aramaki Y; Hosfield DJ; Hori A; Baba A; Miki H
    Eur J Med Chem; 2013 Mar; 61():49-60. PubMed ID: 22819505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
    Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.
    Duan YT; Yao YF; Huang W; Makawana JA; Teraiya SB; Thumar NJ; Tang DJ; Tao XX; Wang ZC; Jiang AQ; Zhu HL
    Bioorg Med Chem; 2014 Jun; 22(11):2947-54. PubMed ID: 24792811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
    Wang R; Zhao X; Yu S; Chen Y; Cui H; Wu T; Hao C; Zhao D; Cheng M
    Bioorg Chem; 2020 Sep; 102():104092. PubMed ID: 32707280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives.
    Zhang LR; Liu ZJ; Zhang H; Sun J; Luo Y; Zhao TT; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Jun; 20(11):3615-21. PubMed ID: 22541051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of novel imidazo[1,2-a][1,3,5]triazines and their derivatives as focal adhesion kinase inhibitors with antitumor activity.
    Dao P; Smith N; Tomkiewicz-Raulet C; Yen-Pon E; Camacho-Artacho M; Lietha D; Herbeuval JP; Coumoul X; Garbay C; Chen H
    J Med Chem; 2015 Jan; 58(1):237-51. PubMed ID: 25180654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors.
    Elsayed MS; El-Araby ME; Serya RA; El-Khatib AH; Linscheid MW; Abouzid KA
    Eur J Med Chem; 2013 Mar; 61():122-31. PubMed ID: 23063746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and quantum chemical studies of new 4-aminoquinazoline derivatives as Aurora A/B kinase inhibitors.
    Zheng M; Zheng Y; Xue Y; Liu Y; An L; Zhang L; Ji M; Xue B; Wu X; Gong X; Gu N; Zhan X
    Chem Biol Drug Des; 2013 Mar; 81(3):399-407. PubMed ID: 23279802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
    Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
    Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.
    Kim KH; Wissner A; Floyd MB; Fraser HL; Wang YD; Dushin RG; Hu Y; Olland A; Guo B; Arndt K
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5225-8. PubMed ID: 19628388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel 1,2,4-triazine scaffold as FAK inhibitors with antitumor activity.
    Dao P; Lietha D; Etheve-Quelquejeu M; Garbay C; Chen H
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1727-1730. PubMed ID: 28284808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach.
    Kumar V; Singh P; Parate S; Singh R; Ro HS; Song KS; Lee KW; Park YM
    J Mol Graph Model; 2024 Jul; 130():108789. PubMed ID: 38718434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new type of mixed anhydride and its applications to the synthesis of 7-substituted 8-chloro-5,5-dioxoimidazo[1,2-b][1,4,2]benzodithiazines with in vitro antitumor activity.
    Brzozowski Z; Saczewski F
    J Med Chem; 2002 Jan; 45(2):430-7. PubMed ID: 11784147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of a real-time activity probe for focal adhesion kinase.
    Beck JR; Zhou X; Casey GR; Stains CI
    Anal Chim Acta; 2015 Oct; 897():62-8. PubMed ID: 26515006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors.
    Chekanov MO; Ostrynska OV; Synyugin AR; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):338-43. PubMed ID: 23578312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel benzopyridothiadiazepines as potential active antitumor agents.
    Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
    J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors.
    Shaaban MR; Saleh TS; Mayhoub AS; Farag AM
    Eur J Med Chem; 2011 Sep; 46(9):3690-5. PubMed ID: 21664013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.
    Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H
    Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.